DK2410048T3 - Fremgangsmåde til fremstilling af en forbindelse af interesse i en filamentøs svampecelle - Google Patents

Fremgangsmåde til fremstilling af en forbindelse af interesse i en filamentøs svampecelle Download PDF

Info

Publication number
DK2410048T3
DK2410048T3 DK11164234.4T DK11164234T DK2410048T3 DK 2410048 T3 DK2410048 T3 DK 2410048T3 DK 11164234 T DK11164234 T DK 11164234T DK 2410048 T3 DK2410048 T3 DK 2410048T3
Authority
DK
Denmark
Prior art keywords
sequence
codon
coding sequence
synonymous
nucleotide
Prior art date
Application number
DK11164234.4T
Other languages
English (en)
Inventor
Johannes Andries Roubos
Serge Petrus Donkers
Hein Stam
Van Noã«L Nicolaas Maria Elisabeth Peij
Original Assignee
Dsm Ip Assets Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dsm Ip Assets Bv filed Critical Dsm Ip Assets Bv
Application granted granted Critical
Publication of DK2410048T3 publication Critical patent/DK2410048T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2405—Glucanases
    • C12N9/2408—Glucanases acting on alpha -1,4-glucosidic bonds
    • C12N9/2411—Amylases
    • C12N9/2414—Alpha-amylase (3.2.1.1.)
    • C12N9/2417—Alpha-amylase (3.2.1.1.) from microbiological source
    • C12N9/242—Fungal source
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/18—Carboxylic ester hydrolases (3.1.1)
    • C12N9/20—Triglyceride splitting, e.g. by means of lipase

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)

Claims (7)

1. Fremgangsmåde til fremstilling af en nukleotidsekvens, der omfatter trinene: - tilvejebringelse af en synonym nukleotidkodende sekvens med optimeret kodonfrekvens, således at en nativ kodon er blevet udskiftet med en synonym kodon, hvilken synonyme kodon koder for den samme aminosyre som den native kodon og har en højere frekvens i kodonanvendelse som defineret i tabel 1 end den native kodon, hvor den optimerede kodonfrekvens er således, at mindst 10 %, 15 %, 20 %, 25 %, 50 %, 75 %, 80 %, 85 %, 90 % og mest fortrinsvis mindst 95 % af de native kodoner er blevet udskiftet med en synonym kodon, idet den synonyme kodon ændrer kodonfrekvensen, således at værdien af den absolutte forskel mellem procenten for den synonyme kodon i frekvensen og den listede optimale procent bliver mindre efter modificering ved anvendelse af følgende liste over optimale procenter: cystein ved TGC (100 %) ; phenylalanin ved TTC (100 %) ; histidin ved CAC (100 %); lysin ved AAG (100 %); asparagin ved AAC (100 %); glutamin ved CAG (100 %); tyrosin ved TAC (100 %); alanin kodes ved GCT (38 %) , GCC (51 %) eller GCG (11 %) ; aspartat ved GAC (64 %); glutamat ved GAG (74 %); glycin ved GGT (49 %), GGC (35 %), GGA (16 %); isoleucin ved ATT (27 %), ATC (73 %); leucin ved TTG (13 %) , CTT (17 %) , CTC (38 %) , CTG (32 %) ; prolin ved CCT (36 %) , CCC (64 %) ; arginin ved CGT (49 %), CGC (51 %); serin ved TCT (21 %) , TCC (44 %) , TCG (14 %), AGC (21 %); threonin ved ACT (30 %), ACC (70 %) og/eller valin ved GTT (27 %), GTC (54 %), GTG (19 %) , hvor kodon-egnetheden af den synonyme nukleotidkodende sekvens med optimeret kodonfrekvens har en egnetshedsværdi, der er mindst 70 %, 80 %, 90 %, 95 %, fortrinsvis 96 %, 97 %, 98 % og mest fortrinsvis >98 %, where kodon-egnetheden beregnes ved hjælp af følgende funktion:
hvor g symboliserer en nukleotidkodende sekvens, \g\ dens længde, c (k) dens k'ende kodon, rc (CW, er en ønsket andel af kodon c (k) og rc en faktisk andel i den nukleotidkodende sekvens g, og eventuelt - operabel kobling af den synonyme nukleotidkodende sekvens til en kontrolsekvens, såsom: - én translationstermineringssekvens orienteret i 5' mod 3' -retningen, der er udvalgt fra følgende liste af sekvenser: TAAG, TAGA og TAAA, fortrinsvis TAAA, og/eller - én translationsinitiatorkodende sekvens orienteret i 5' mod 3'-retningen, der er udvalgt fra følgende liste af sekvenser: GCTACCCCC; GCTACCTCC; GCTACCCTC; GCTACCTTC; GCTCCCCCC; GCTCCCTCC; GCTCCCCTC; GCTCCCTTC; GCTGCCCCC; GCTGCCTCC; GCTGCCCTC; GCTGCCTTC; GCTTCCCCC; GCTTCCTCC; GCTTCCCTC; og GCTTCCTTC, fortrinsvis GCT TCC TTC. Tabel 1: Optimal kodonfrekvens for filamentøs svamp af synonyme kodoner i %
2. Fremgangsmåde ifølge krav 1, hvor den synonyme nukleotidkodende sekvens er omvendt konstrueret fra en aminosyresekvens.
3. Fremgangsmåde ifølge krav 1 eller 2, hvor den synonyme nukleotidkodende sekvens omfatter en signalsekvens.
4. Fremgangsmåde ifølge et hvilket som helst af kravene 1 til 3, der omfatter yderligere tilvejebringelse af ét intron og den synonyme nukleotidkodende sekvens.
5. Fremgangsmåde ifølge et hvilket som helst af kravene 1 til 4, der omfatter yderligere tilvejebringelse af en translationsinitiatorsekvens, hvilken translationsinitiatorsekvens omfatter nukleinsyresekvensen som defineret ved konsensus-translationsinitiatorsekvensen: 5'-mwChkyCAmv-3' (SEQ ID NO: 16) ved anvendelse af flertydige koder for nukleotider: m (A/C) ; r (A/G) ; w (A/T) ; s (C/G) ; y (C/T); k (G/T); v (A/C/G) ; h (A/C/T) ; d (A/G/T) ; b (C/G/T) ; n (A/C/G/T), og konsensus-translationsinitiatorsekvensen fortrinsvis er én, der er udvalgt fra følgende liste: 5'- mwChkyCAAA-3' (SEQ ID NO: 17), 5' -mwChkyCACA-3' (SEQ ID NO: 18) og 5'-mwChkyCAAG-3' (SEQ ID NO: 19).
6. Fremgangsmåde ifølge krav 5, hvor translationsinitiatorsekvensen er 5'-CACCGTCAAA-3' (SEQ ID NO: 22) eller 5'-CGCAGTCAAG-3' (SEQ ID NO: 23).
7. Fremgangsmåde ifølge et hvilket som helst af kravene 1 til 6, hvor nukleotidsekvensen er indbefattet i en nukleinsyrekonstruktion eller ekspressionsvektor.
DK11164234.4T 2005-01-24 2006-01-24 Fremgangsmåde til fremstilling af en forbindelse af interesse i en filamentøs svampecelle DK2410048T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05100408 2005-01-24
EP06701683A EP1841861A1 (en) 2005-01-24 2006-01-24 Method for producing a compound of interest in a filamentous fungal cell

Publications (1)

Publication Number Publication Date
DK2410048T3 true DK2410048T3 (da) 2016-11-28

Family

ID=36119512

Family Applications (1)

Application Number Title Priority Date Filing Date
DK11164234.4T DK2410048T3 (da) 2005-01-24 2006-01-24 Fremgangsmåde til fremstilling af en forbindelse af interesse i en filamentøs svampecelle

Country Status (10)

Country Link
US (1) US7888489B2 (da)
EP (2) EP2410048B1 (da)
JP (1) JP2008527985A (da)
CN (1) CN101107354B (da)
AU (1) AU2006207463B2 (da)
CA (1) CA2595056A1 (da)
DK (1) DK2410048T3 (da)
ES (1) ES2601200T3 (da)
PL (1) PL2410048T3 (da)
WO (1) WO2006077258A1 (da)

Families Citing this family (90)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8637280B2 (en) 2005-12-01 2014-01-28 Adcuram Nutrition Holding Gmbh Genes useful for the industrial production of citric acid
CA2657975A1 (en) * 2006-06-29 2008-01-03 Dsm Ip Assets B.V. A method for achieving improved polypeptide expression
WO2008053018A2 (en) 2006-11-02 2008-05-08 Dsm Ip Assets B.V. Improved production of secreted proteins by filamentous fungi
EP2631295A3 (en) 2007-02-15 2014-01-01 DSM IP Assets B.V. A recombinant host cell for the production of a compound of interest
EP2123772A1 (en) 2008-04-29 2009-11-25 DSM IP Assets B.V. Beta-lactam antibiotic producing strains
EP2392649A3 (en) 2008-08-05 2012-01-11 DSM IP Assets B.V. Adipoyl-7-ADCA producing strains
WO2010069914A1 (en) * 2008-12-19 2010-06-24 Dsm Ip Assets B.V. Statin transcription regulators
WO2010102982A1 (en) 2009-03-10 2010-09-16 Dsm Ip Assets B.V. Method for improving the yield of a polypeptide
US8703463B2 (en) 2009-03-10 2014-04-22 Dsm Ip Assets B.V. Pregastric esterase and derivatives thereof
WO2010121933A1 (en) 2009-04-22 2010-10-28 Dsm Ip Assets B.V. Process for the production of a recombinant polypeptide of interest
GB0908770D0 (en) * 2009-04-24 2009-07-01 Danisco Method
WO2010122141A1 (en) 2009-04-24 2010-10-28 Dsm Ip Assets B.V. Carbohydrate degrading polypeptide and uses thereof
UA108853C2 (uk) 2009-07-10 2015-06-25 Спосіб ферментації галактози
WO2011009700A1 (en) 2009-07-22 2011-01-27 Dsm Ip Assets B.V. Improved host cell for the production of a compound of interest
AU2010291265A1 (en) 2009-09-03 2012-03-15 Dsm Ip Assets B.V. Baking enzyme composition as SSL replacer
WO2011031876A1 (en) 2009-09-09 2011-03-17 Qd Vision, Inc. Formulations including nanoparticles
WO2011054899A1 (en) 2009-11-04 2011-05-12 Dsm Ip Assets B.V. Talaromyces transformants
AU2011214327B2 (en) 2010-02-11 2014-09-18 Dsm Ip Assets B.V. Polypeptide having cellobiohydrolase activity and uses thereof
CA2789301A1 (en) 2010-02-11 2011-08-18 Dsm Ip Assets B.V. Host cell capable of producing enzymes useful for degradation of lignocellulosic material
PL2588492T3 (pl) 2010-06-29 2016-09-30 Polipeptyd mający aktywność beta-glukozydazy i jego zastosowania
WO2012000891A1 (en) 2010-06-29 2012-01-05 Dsm Ip Assets B.V. Polypeptide having carbohydrate degrading activity and uses thereof
EP2588603B1 (en) 2010-06-29 2017-03-22 DSM IP Assets B.V. Polypeptide having or assisting in carbohydrate material degrading activity and uses thereof
CA2803982A1 (en) 2010-06-29 2012-01-05 Dsm Ip Assets B.V. Polypeptide having beta-glucosidase activity and uses thereof
US9163223B2 (en) 2010-06-29 2015-10-20 Dsm Ip Assets B.V. Polypeptide having acetyl xylan esterase activity and uses thereof
AU2011273685B2 (en) 2010-06-29 2014-12-11 Dsm Ip Assets B.V. Polypeptide having swollenin activity and uses thereof
CA2803222A1 (en) 2010-07-01 2012-01-05 Dsm Ip Assets B.V. A method for the production of a compound of interest
CA2813513A1 (en) 2010-10-13 2012-04-19 Dsm Ip Assets B.V. Polypeptides with permease activity
CN103348005B (zh) 2011-01-31 2015-03-18 帝斯曼知识产权资产管理有限公司 突变体纤维二糖水解酶
WO2012123429A1 (en) 2011-03-11 2012-09-20 Dsm Ip Assets B.V. Vector-host system
WO2013007821A1 (en) 2011-07-14 2013-01-17 Dsm Ip Assets B.V. Screening method
AR087423A1 (es) 2011-08-04 2014-03-19 Dsm Ip Assets Bv Celula capaz de fermentar azucares pentosas
EP2554668A1 (en) 2011-08-04 2013-02-06 DSM IP Assets B.V. A pentose sugar fermenting cell
EP2620496B1 (en) 2012-01-30 2015-06-03 DSM IP Assets B.V. Alpha-amylase
EP2857511B1 (en) * 2012-05-31 2018-07-04 Meiji Seika Pharma Co., Ltd. Method for producing armoracia rusticana-derived peroxidase recombinant protein using filamentous fungi
EP3327112B1 (en) 2012-07-19 2020-02-12 DSM IP Assets B.V. Agse-deficient strain
DK2877576T3 (da) 2012-07-24 2019-08-12 Bp Corp North America Inc Xyloseisomeraser og anvendelser deraf
WO2014033019A1 (en) 2012-08-28 2014-03-06 Dsm Ip Assets B.V. Yeast strains engineered to produce ethanol from acetate
IN2015DN01041A (da) 2012-08-28 2015-06-26 Dsm Ip Assets Bv
EP2898076B1 (en) 2012-09-19 2018-03-07 DSM IP Assets B.V. Cell modification method using essential genes as markers and optionally recycling these
PL2909305T3 (pl) 2012-10-16 2019-06-28 Dsm Ip Assets B.V. Komórki o ulepszonej konwersji pentozy
EP3686280B1 (en) 2013-02-04 2022-06-22 DSM IP Assets B.V. Carbohydrate degrading polypeptide and uses thereof
WO2014142647A1 (en) 2013-03-14 2014-09-18 Wageningen Universiteit Fungals strains with improved citric acid and itaconic acid production
WO2014202622A2 (en) 2013-06-19 2014-12-24 Dsm Ip Assets B.V. Rasamsonia gene and use thereof
WO2014202620A2 (en) 2013-06-19 2014-12-24 Dsm Ip Assets B.V. Rasamsonia gene and use thereof
WO2014202624A2 (en) 2013-06-19 2014-12-24 Dsm Ip Assets B.V. Rasamsonia gene and use thereof
WO2014202616A2 (en) 2013-06-19 2014-12-24 Dsm Ip Assets B.V. Rasamsonia gene and use thereof
WO2014202621A1 (en) 2013-06-20 2014-12-24 Dsm Ip Assets B.V. Carbohydrate degrading polypeptide and uses thereof
EP3077517B1 (en) 2013-12-02 2018-10-17 DSM IP Assets B.V. Ice structuring protein
WO2015177152A1 (en) 2014-05-19 2015-11-26 Dsm Ip Assets B.V. Proline-specific endoprotease
WO2015177153A1 (en) 2014-05-19 2015-11-26 Dsm Ip Assets B.V. Proline-specific endoprotease
MX375798B (es) 2014-05-19 2025-03-07 Dsm Ip Assets Bv Endoproteasa específica para prolina.
WO2016012429A1 (en) 2014-07-24 2016-01-28 Dsm Ip Assets B.V. Yeast cell with improved pentose transport
US10619170B2 (en) 2015-01-06 2020-04-14 Dsm Ip Assets B.V. CRISPR-CAS system for a yeast host cell
DK3242950T3 (da) 2015-01-06 2021-12-20 Dsm Ip Assets Bv Crispr-cas-system til en trådformet svampeværtscelle
EP3242948B1 (en) 2015-01-06 2021-12-22 DSM IP Assets B.V. A crispr-cas system for a yarrowia host cell
AR104205A1 (es) 2015-04-09 2017-07-05 Dsm Ip Assets Bv Fosfolipasa c
AU2016273208B2 (en) 2015-06-02 2021-01-21 Dsm Ip Assets B.V. Use of ice structuring protein AFP19 expressed in filamentous fungal strains for preparing food
US10724040B2 (en) 2015-07-15 2020-07-28 The Penn State Research Foundation mRNA sequences to control co-translational folding of proteins
WO2017050652A1 (en) 2015-09-25 2017-03-30 Dsm Ip Assets B.V. Asparaginase
JP6938482B2 (ja) * 2015-10-02 2021-09-22 ユニバーシティー オブ ユタ リサーチ ファンデーション 調節可能なリボソーム翻訳速度のための組成物および使用法
EP4361240A3 (en) 2015-11-17 2024-07-31 DSM IP Assets B.V. Preparation of a stable beer
US10829748B2 (en) 2016-06-10 2020-11-10 Dsm Ip Assets B.V. Mutant lipase and use thereof
WO2018013821A1 (en) 2016-07-13 2018-01-18 Dsm Ip Assets B.V. A crispr-cas system for an algal host cell
WO2018019948A1 (en) 2016-07-29 2018-02-01 Dsm Ip Assets B.V. Polypeptides having cellulolytic enhancing activity and uses thereof
FI3516056T3 (fi) 2016-09-23 2025-02-28 Dsm Ip Assets Bv Opas-rna:n ilmentämisjärjestelmä isäntäsolulle
WO2018114940A1 (en) 2016-12-21 2018-06-28 Dsm Ip Assets B.V. Lipolytic enzyme variants
US10918113B2 (en) 2016-12-21 2021-02-16 Dsm Ip Assets B.V. Lipolytic enzyme variants
WO2018114938A1 (en) 2016-12-21 2018-06-28 Dsm Ip Assets B.V. Lipolytic enzyme variants
WO2018114912A1 (en) 2016-12-21 2018-06-28 Dsm Ip Assets B.V. Lipolytic enzyme variants
EP3559217A1 (en) 2016-12-22 2019-10-30 DSM IP Assets B.V. Glutathione reductase
MX2019009551A (es) * 2017-02-20 2020-01-30 Novozymes As Enzima lipolitica para usarse en horneado.
EP3596199A1 (en) 2017-03-13 2020-01-22 DSM IP Assets B.V. Zinc binuclear cluster transcriptional regulator-deficient strain
CN107353327A (zh) * 2017-03-30 2017-11-17 南京百斯杰生物工程有限公司 植酸酶在黑曲霉中表达
US20200032252A1 (en) 2017-04-06 2020-01-30 Dsm Ip Assets B.V. Self-guiding integration construct (sgic)
PL3688149T3 (pl) 2017-09-26 2025-03-24 Bunge Global Innovation, Llc. Enzymatyczne usuwanie substratów chlorofilowych z olejów na bazie triacyloglicerolu
CN111492059A (zh) 2017-12-20 2020-08-04 帝斯曼知识产权资产管理有限公司 在宿主细胞中进行基因组编辑的方法
MX429191B (es) 2018-04-05 2025-11-13 Dsm Ip Assets Bv Alfa-amilasa maltogénica variante.
WO2019215102A1 (en) 2018-05-09 2019-11-14 Dsm Ip Assets B.V. Crispr transient expression construct (ctec)
US20230080079A1 (en) 2018-05-18 2023-03-16 Dsm Ip Assets B.V. Mutant lipase and use thereof
WO2019219904A2 (en) 2018-05-18 2019-11-21 Dsm Ip Assets B.V. Mutant lipase and use thereof
BR112020025589A2 (pt) 2018-06-19 2021-03-23 Dsm Ip Assets B.V. variantes de enzima lipolítica
US12365885B2 (en) 2018-11-15 2025-07-22 Dsm Ip Assets B.V. Production of riboflavin
EP3891281A1 (en) 2018-12-05 2021-10-13 DSM IP Assets B.V. Crispr guide-rna expression strategies for multiplex genome engineering
EP3946720A1 (en) 2019-03-27 2022-02-09 Bunge Global Innovation, LLC. Silica adsorbent treatment for removal of chlorophyll derivatives from triacylglycerol-based oils
CN111951891B (zh) * 2019-05-16 2022-11-01 清华大学 确定优化的核苷酸序列的方法和系统
BR112022017482A2 (pt) 2020-03-10 2022-10-18 Dsm Ip Assets Bv Pó lácteo com lactose reduzida
EP4355762A1 (en) 2021-06-17 2024-04-24 DSM IP Assets B.V. Improved bacillus host cell
EP4525626A1 (en) 2022-05-16 2025-03-26 DSM IP Assets B.V. Lipolytic enzyme variants
EP4424820A1 (en) 2023-03-03 2024-09-04 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Designed synzip protein domains for generating artificial nonribosomal peptide synthetases and hybrids thereof
EP4743572A1 (en) 2023-07-11 2026-05-20 DSM IP Assets B.V. ARGININE PROTEIN DEIMINASE

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK122686D0 (da) 1986-03-17 1986-03-17 Novo Industri As Fremstilling af proteiner
US5766912A (en) 1986-03-17 1998-06-16 Novo Nordisk A/S Humicola lipase produced in aspergillus
CA1333777C (en) 1988-07-01 1995-01-03 Randy M. Berka Aspartic proteinase deficient filamentous fungi
CA1341226C (en) 1988-08-16 2001-05-01 Wim Van Hartingsveldt Gene replacement as a tool for the construction of aspergillus strains
DK0635574T3 (da) 1993-07-23 2003-08-11 Dsm Ip Assets Bv Selektionsmarkørgenfri rekombinantstammer, en fremgangsmåde til fremstilling af disse og anvendelse af disse stammer
ATE294871T1 (de) 1994-06-30 2005-05-15 Novozymes Biotech Inc Nicht-toxisches, nicht-toxigenes, nicht- pathogenes fusarium expressionssystem und darin zu verwendende promotoren und terminatoren
US5795737A (en) 1994-09-19 1998-08-18 The General Hospital Corporation High level expression of proteins
AU3802595A (en) 1994-11-08 1996-05-31 Novo Nordisk A/S Tripeptidyl aminopeptidase
WO1997006261A2 (en) 1995-08-03 1997-02-20 Gist-Brocades B.V. THE USE OF HOMOLOGOUS amdS GENES AS SELECTABLE MARKERS
ATE317005T1 (de) 1996-03-27 2006-02-15 Novozymes As Alkaline-phosphatase-defiziente, filamentöse pilze
ATE313620T1 (de) 1996-09-19 2006-01-15 Novozymes As Wirtszellen und methoden für die produktion von proteinen
JPH10155493A (ja) 1996-10-04 1998-06-16 Sankyo Co Ltd アスペルギルス属由来のホスホリパーゼa1をコードする遺伝子
PL336345A1 (en) 1997-04-11 2000-06-19 Dsm Nv Genic conversion as a tool for constructing recombined filiform fungi
ES2287989T3 (es) 1997-12-22 2007-12-16 Dsm Ip Assets B.V. Clonacion de expresion en hongos filamentosos.
ES2317706T3 (es) 1998-12-23 2009-04-16 Novozymes A/S Metodo para produicir polipeptidos en celulas mutantes de aspergillus.
WO2001021779A2 (en) 1999-09-17 2001-03-29 Dsm N.V. Penicillium chrysogenum transcriptional activator blar, a pathway specific regulator of beta-lactam biosynthesis, and uses therof
CN1253575C (zh) * 1999-11-30 2006-04-26 诺沃奇梅兹生物技术有限公司 用共有翻译起始区序列制备多肽的方法
US6818752B2 (en) 2000-01-31 2004-11-16 Biocatalytics, Inc. Synthetic genes for enhanced expression
CN102174535B (zh) 2000-03-14 2014-04-09 诺维信公司 在制备多肽的方法中有效的真菌转录激活因子
WO2001072783A2 (en) 2000-03-24 2001-10-04 Genencor International, Inc. Production of secreted proteins by recombinant eukaryotic cells
GB0014288D0 (en) * 2000-06-10 2000-08-02 Smithkline Beecham Biolog Vaccine
NZ526101A (en) * 2000-12-22 2005-06-24 Janssen Pharmaceutica Nv Genes for drug target identification in yeast and fungi i.e. candida that are involved in apoptosis
EP1231272A3 (en) * 2001-02-08 2002-11-13 Laboratorios Ovejero S.A. Procedure for obtaining bovine chymosin (rennin), curd
EP1527164A4 (en) * 2001-05-04 2006-02-01 Univ Florida CLONING AND SEQUENCING OF PYRUVATE CARBOXYLASE (PDC) GENES FROM BACTERIA AND USES THEREOF
WO2003070957A2 (en) * 2002-02-20 2003-08-28 Novozymes A/S Plant polypeptide production
EP1490494A1 (en) * 2002-04-01 2004-12-29 Walter Reed Army Institute of Research Method of designing synthetic nucleic acid sequences for optimal protein expression in a host cell
EP1590444A2 (en) 2003-02-05 2005-11-02 DSM IP Assets B.V. Use of oxalate deficient aspergillus niger strains for producing a polypeptide
DK1613761T3 (da) 2003-03-31 2009-12-14 Novozymes Inc Fremgangsmåder til fremstilling af biologiske stoffer i enzymdefekte mutanter af Aspergillus niger
JP4228072B2 (ja) * 2003-06-04 2009-02-25 独立行政法人農業・食品産業技術総合研究機構 アビジンをコードする人工合成遺伝子
CA2559827A1 (en) 2004-04-02 2005-10-13 Dsm Ip Assets B.V. Filamentous fungal mutants with improved homologous recombination efficiency
CA2568788A1 (en) 2004-06-16 2005-12-29 Dsm Ip Assets B.V. Production of polypeptides by improved secretion
EP1856263A1 (en) * 2005-03-01 2007-11-21 DSMIP Assets B.V. Aspergillus promotors for expressing a gene in a fungal cell

Also Published As

Publication number Publication date
WO2006077258A1 (en) 2006-07-27
AU2006207463A1 (en) 2006-07-27
EP2410048B1 (en) 2016-08-10
ES2601200T3 (es) 2017-02-14
CN101107354A (zh) 2008-01-16
CN101107354B (zh) 2012-05-30
EP2410048A1 (en) 2012-01-25
EP1841861A1 (en) 2007-10-10
JP2008527985A (ja) 2008-07-31
PL2410048T3 (pl) 2017-02-28
AU2006207463B2 (en) 2011-03-17
CA2595056A1 (en) 2006-07-27
US7888489B2 (en) 2011-02-15
US20080118965A1 (en) 2008-05-22

Similar Documents

Publication Publication Date Title
EP2410048B1 (en) Method for producing a compound of interest in a filamentous fungal cell
CN102414323B (zh) 用于生产感兴趣的重组多肽的方法
EP2456872B1 (en) Improved host cell for the production of a compound of interest
CA2834716C (en) Simultaneous site-specific integrations of multiple gene-copies in filamentous fungi
CN101679993A (zh) 适于选择产生目标多肽的文库克隆的表达克隆方法
DK3036324T3 (da) Reguleret PepC-ekspression
EP3487873B1 (en) Improved filamentous fungal host
US20170313997A1 (en) Filamentous Fungal Double-Mutant Host Cells
WO2018172155A1 (en) Improved filamentous fungal host cells
AU2005293516B2 (en) Homologous amdS genes as selectable marker
JP4796840B2 (ja) 糸状菌においてタンパク質を分泌生産する方法
US20220267783A1 (en) Filamentous fungal expression system
AU2011202558A1 (en) Method for producing a compound of interest in a filamentous fungal cell
CN113056552A (zh) 经修饰的丝状真菌宿主细胞
CN114555777A (zh) 经修饰的丝状真菌宿主细胞